We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-14.08%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.9B
AUM Growth
-$2.54B
(-16%)
Cap. Flow
-$55.2M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
2,963
New
235
Increased
680
Reduced
1,092
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$119M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.3M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$14.9M |
| 4 |
UnitedHealth
UNH
|
+$14.3M |
| 5 |
Warner Bros
WBD
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.3M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$18.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$18.1M |
| 4 |
Microsoft
MSFT
|
+$15.4M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
4D Molecular Therapeutics
FDMT
$596M
| $121K | ﹤0.01% |
17,379
| – | – |
|
2627
First Bank
FRBA
$471M
| $121K | ﹤0.01% |
8,675
| – | – |
|
|
MKFG
2628
DELISTED
Markforged Holding Corporation
MKFG
| $121K | ﹤0.01% |
+6,545
| New | +$191K |
|
|
APPH
2629
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $121K | ﹤0.01% |
34,689
-8,266
| -19% | -$29.6K |
|
2630
Miller Industries
MLR
$634M
| $121K | ﹤0.01% |
5,337
| – | – |
|
2631
MeiraGTx Holdings
MGTX
$1.28B
| $121K | ﹤0.01% |
15,970
| – | – |
|
2632
Vera Therapeutics
VERA
$2.13B
| $121K | ﹤0.01% |
8,881
| – | – |
|
2633
MediaAlpha
MAX
$798M
| $121K | ﹤0.01% |
12,251
| – | – |
|
2634
Focus Universal
FCUV
$3.76M
| $121K | ﹤0.01% |
+40
| New | +$136K |
|
2635
FVCBankcorp
FVCB
$340M
| $120K | ﹤0.01% |
+7,985
| New | +$128K |
|
2636
NerdWallet
NRDS
$630M
| $120K | ﹤0.01% |
+15,148
| New | +$154K |
|
2637
Digimarc Corp
DMRC
$161M
| $120K | ﹤0.01% |
8,465
| – | – |
|
2638
Madison Square Garden
MSGS
$10.2B
| $119K | ﹤0.01% |
789
+89
| +13% | +$14.4K |
|
2639
Huntsman Corp
HUN
$1.82B
| $119K | ﹤0.01% |
4,194
+50
| +1% | +$1.69K |
|
2640
Alico
ALCO
$307M
| $119K | ﹤0.01% |
+3,337
| New | +$133K |
|
2641
Certara
CERT
$1.2B
| $118K | ﹤0.01% |
5,520
+346
| +7% | +$6.83K |
|
2642
Citi Trends
CTRN
$627M
| $118K | ﹤0.01% |
5,006
| – | – |
|
2643
New Fortress Energy
NFE
$94M
| $118K | ﹤0.01% |
2,987
+1,274
| +74% | +$54.9K |
|
2644
1-800-Flowers.com
FLWS
$259M
| $118K | ﹤0.01% |
12,420
-3,138
| -20% | -$34.7K |
|
2645
Lifecore Biomedical
LFCR
$182M
| $118K | ﹤0.01% |
11,839
-3,171
| -21% | -$31.4K |
|
2646
OraSure Technologies
OSUR
$265M
| $117K | ﹤0.01% |
43,288
| – | – |
|
2647
VistaGen Therapeutics
VTGN
$11.7M
| $117K | ﹤0.01% |
4,443
| – | – |
|
|
ITIC
2648
Investors Title Co
ITIC
$526M
| $117K | ﹤0.01% |
747
| – | – |
|
2649
GeneDx Holdings
WGS
$2.42B
| $117K | ﹤0.01% |
+2,818
| New | +$191K |
|
2650
PCB Bancorp
PCB
$401M
| $116K | ﹤0.01% |
+6,228
| New | +$127K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
EIM
OSAM
MetLife Investment Management's Q2 2022 Portfolio in Review
As of Q2 2022, MetLife Investment Management held 2,963 positions worth $12.9B, down 16% from $15.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
MetLife Investment Management's Q2 2022 filing shows 235 new, 680 increased, 1,092 reduced and 109 closed positions. Its largest new stake was Airbnb: 23,229 shares worth $2.07M. The largest sale was Apple, an estimated $21.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- MetLife Investment Management's largest Q2 2022 buy was Airbnb: 23,229 shares worth $2.07M.
- MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $119M increase.
- MetLife Investment Management's biggest Q2 2022 reduction was Apple, cutting an estimated $21.3M.
- MetLife Investment Management fully exited Cerner Corp in Q2 2022, selling an estimated $7.49M.
- MetLife Investment Management's ten largest holdings make up 24% of its $12.9B portfolio in Q2 2022.
- MetLife Investment Management opened 235 new positions and closed 109 in Q2 2022.
- MetLife Investment Management's portfolio value fell 16% quarter-over-quarter to $12.9B.
Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.